HRP20050176A2 - Novel processes for making - and a new crystalline form of-leflunomide - Google Patents
Novel processes for making - and a new crystalline form of-leflunomideInfo
- Publication number
- HRP20050176A2 HRP20050176A2 HR20050176A HRP20050176A HRP20050176A2 HR P20050176 A2 HRP20050176 A2 HR P20050176A2 HR 20050176 A HR20050176 A HR 20050176A HR P20050176 A HRP20050176 A HR P20050176A HR P20050176 A2 HRP20050176 A2 HR P20050176A2
- Authority
- HR
- Croatia
- Prior art keywords
- leflunomide
- making
- crystalline form
- new crystalline
- novel processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17123799P | 1999-12-16 | 1999-12-16 | |
US17122899P | 1999-12-16 | 1999-12-16 | |
US18264700P | 2000-02-15 | 2000-02-15 | |
US20241600P | 2000-05-08 | 2000-05-08 | |
PCT/US2000/033866 WO2001043742A1 (en) | 1999-12-16 | 2000-12-14 | Novel processes for making- and a new crystalline form of- leflunomide |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20050176A2 true HRP20050176A2 (en) | 2005-08-31 |
Family
ID=27496942
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20020521A HRP20020521A2 (en) | 1999-12-16 | 2002-06-14 | Novel processes for making - and a new crystalline form of - leflunomide |
HR20050176A HRP20050176A2 (en) | 1999-12-16 | 2005-02-23 | Novel processes for making - and a new crystalline form of-leflunomide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20020521A HRP20020521A2 (en) | 1999-12-16 | 2002-06-14 | Novel processes for making - and a new crystalline form of - leflunomide |
Country Status (15)
Country | Link |
---|---|
US (3) | US6610718B2 (xx) |
EP (1) | EP1242077A4 (xx) |
JP (1) | JP2003517011A (xx) |
KR (1) | KR20020067545A (xx) |
CN (1) | CN1411373A (xx) |
AU (1) | AU779931B2 (xx) |
CA (1) | CA2397601A1 (xx) |
CZ (1) | CZ20022000A3 (xx) |
HR (2) | HRP20020521A2 (xx) |
HU (1) | HUP0204069A3 (xx) |
IL (1) | IL149792A0 (xx) |
PL (1) | PL356243A1 (xx) |
SK (1) | SK8332002A3 (xx) |
WO (1) | WO2001043742A1 (xx) |
YU (1) | YU45102A (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE207065T1 (de) * | 1997-08-08 | 2001-11-15 | Aventis Pharma Gmbh | Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid |
KR20020067545A (ko) * | 1999-12-16 | 2002-08-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레플루노마이드의 신규 제조 방법 및 이의 신규 결정형 |
US20030153585A1 (en) * | 2000-01-13 | 2003-08-14 | Sven-Alexander Schreder | Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
PL366088A1 (en) * | 2000-02-15 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | A method for synthesizing leflunomide |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
WO2006103506A1 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Sertraline-containing pharmaceutical compositions and a process for preparation thereof |
CN101563082A (zh) * | 2006-09-05 | 2009-10-21 | 窦德献 | 治疗免疫介导性皮肤病的组合物和方法 |
CN101143834B (zh) * | 2006-09-15 | 2010-09-08 | 欣凯医药化工中间体(上海)有限公司 | N-(4-三氟甲基苯)-2-氰基-3-羟基丁烯酰胺钠盐的多晶型及其制备方法 |
WO2009004374A1 (en) | 2007-06-29 | 2009-01-08 | Generics [Uk] Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
AU2008315757A1 (en) | 2007-10-24 | 2009-04-30 | Generics [Uk] Limited | Novel crystalline forms |
CA2712860C (en) | 2008-02-08 | 2014-11-18 | Abhay Gaitonde | Process for preparing bosentan |
CN102272108A (zh) | 2008-11-03 | 2011-12-07 | 基因里克斯(英国)有限公司 | 用于分析波生坦及相关物质的hplc方法以及这些物质作为参比标准和标记的用途 |
CN101817797B (zh) * | 2009-02-26 | 2013-04-10 | 江苏亚邦爱普森药业有限公司 | 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法 |
AR099354A1 (es) | 2013-11-15 | 2016-07-20 | Akebia Therapeutics Inc | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos |
US11801232B2 (en) * | 2019-11-27 | 2023-10-31 | Yale University | Targeting of ARID1A-deficient cancers by inhibiting de novo pyrimidine synthesis pathway |
CN112898215B (zh) * | 2021-02-04 | 2022-11-08 | 美罗药业股份有限公司 | 一种来氟米特晶型i的制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
HU222234B1 (hu) * | 1990-05-18 | 2003-05-28 | Aventis Pharma Deutschland Gmbh. | Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
DE19610955A1 (de) * | 1996-03-20 | 1997-09-25 | Hoechst Ag | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
DE19711800A1 (de) * | 1997-03-21 | 1998-09-24 | Hoechst Ag | Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung |
ATE207065T1 (de) * | 1997-08-08 | 2001-11-15 | Aventis Pharma Gmbh | Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid |
EP0933633A1 (en) * | 1997-12-11 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Process for obtaining L-dihydroorotic acid and use thereof |
US7691890B2 (en) * | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
US6303652B1 (en) * | 1998-08-21 | 2001-10-16 | Hughes Institute | BTK inhibitors and methods for their identification and use |
DE19908527C2 (de) * | 1999-02-26 | 2001-08-30 | Aventis Pharma Gmbh | Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
EP1196414B1 (en) * | 1999-06-25 | 2003-09-03 | Vertex Pharmaceuticals Incorporated | Prodrugs of carbamate inhibitors of impdh |
KR20020067545A (ko) * | 1999-12-16 | 2002-08-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레플루노마이드의 신규 제조 방법 및 이의 신규 결정형 |
PL366088A1 (en) * | 2000-02-15 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | A method for synthesizing leflunomide |
US6548527B2 (en) * | 2000-03-27 | 2003-04-15 | The General Hospital Corporation | Treatments for immune-mediated ear disorders |
WO2002013822A1 (en) * | 2000-08-14 | 2002-02-21 | Teva Pharmaceutical Industries Ltd. | Micronized leflunomide |
PT1401801E (pt) * | 2000-08-24 | 2007-02-28 | Univ Tennessee Res Foundation | Modulares selectivos de receptor de androgénio e métodos para a sua utilização |
JP4212278B2 (ja) * | 2001-03-01 | 2009-01-21 | 日本たばこ産業株式会社 | 移植片拒絶反応抑制剤 |
US20040229849A1 (en) * | 2002-09-24 | 2004-11-18 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
US20050064038A1 (en) * | 2003-08-13 | 2005-03-24 | Dinh Thomas Q. | Active agent delivery systems including a single layer of a miscible polymer blend, medical devices, and methods |
EP1684820A2 (en) * | 2003-08-13 | 2006-08-02 | Medtronic, Inc. | Active agent delivery systems including a miscible polymer blend, medical devices, and methods |
US20050053600A1 (en) * | 2003-09-09 | 2005-03-10 | Lane Thomas E. | Methods for treating rheumatoid arthritis |
-
2000
- 2000-12-14 KR KR1020027007575A patent/KR20020067545A/ko not_active Application Discontinuation
- 2000-12-14 YU YU45102A patent/YU45102A/sh unknown
- 2000-12-14 US US09/736,727 patent/US6610718B2/en not_active Expired - Fee Related
- 2000-12-14 JP JP2001544880A patent/JP2003517011A/ja active Pending
- 2000-12-14 SK SK833-2002A patent/SK8332002A3/sk unknown
- 2000-12-14 WO PCT/US2000/033866 patent/WO2001043742A1/en not_active Application Discontinuation
- 2000-12-14 CN CN00817283A patent/CN1411373A/zh active Pending
- 2000-12-14 CA CA002397601A patent/CA2397601A1/en not_active Abandoned
- 2000-12-14 CZ CZ20022000A patent/CZ20022000A3/cs unknown
- 2000-12-14 PL PL00356243A patent/PL356243A1/xx not_active Application Discontinuation
- 2000-12-14 EP EP00989253A patent/EP1242077A4/en not_active Withdrawn
- 2000-12-14 IL IL14979200A patent/IL149792A0/xx unknown
- 2000-12-14 HU HU0204069A patent/HUP0204069A3/hu unknown
- 2000-12-14 AU AU25788/01A patent/AU779931B2/en not_active Ceased
-
2002
- 2002-06-14 HR HR20020521A patent/HRP20020521A2/hr not_active Application Discontinuation
-
2003
- 2003-04-08 US US10/410,493 patent/US6806373B2/en not_active Expired - Fee Related
-
2004
- 2004-07-22 US US10/897,778 patent/US20050004191A1/en not_active Abandoned
-
2005
- 2005-02-23 HR HR20050176A patent/HRP20050176A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1411373A (zh) | 2003-04-16 |
KR20020067545A (ko) | 2002-08-22 |
CA2397601A1 (en) | 2001-06-21 |
CZ20022000A3 (cs) | 2003-02-12 |
HUP0204069A3 (en) | 2005-01-28 |
US6806373B2 (en) | 2004-10-19 |
US20010031878A1 (en) | 2001-10-18 |
US20030203952A1 (en) | 2003-10-30 |
EP1242077A4 (en) | 2006-01-04 |
AU779931B2 (en) | 2005-02-17 |
PL356243A1 (en) | 2004-06-28 |
US20050004191A1 (en) | 2005-01-06 |
HRP20020521A2 (en) | 2004-08-31 |
JP2003517011A (ja) | 2003-05-20 |
HUP0204069A2 (hu) | 2003-04-28 |
US6610718B2 (en) | 2003-08-26 |
EP1242077A1 (en) | 2002-09-25 |
SK8332002A3 (en) | 2003-04-01 |
IL149792A0 (en) | 2002-11-10 |
YU45102A (sh) | 2006-01-16 |
WO2001043742A1 (en) | 2001-06-21 |
AU2578801A (en) | 2001-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050176A2 (en) | Novel processes for making - and a new crystalline form of-leflunomide | |
IL159332A0 (en) | A knowledge-engineering protocol-suite | |
IL140079A0 (en) | Process for producing bisphennol a | |
HK1044768A1 (zh) | 晶狀1-甲基碳青霉烯化合物 | |
PL352291A1 (en) | Process for making a pipa-polyol | |
SG99351A1 (en) | Process for the manufacture of a crystalline solid | |
GB9901349D0 (en) | A process | |
IL146972A0 (en) | A substantially crystalline form of melagatran | |
AU140192S (en) | A tool | |
ZA982925B (en) | A new process for preparing a compound | |
AU142007S (en) | A cafetiere | |
GB0014546D0 (en) | A novel process | |
GB9916754D0 (en) | A composition | |
SG99292A1 (en) | A method for producing oxide compounds | |
GB2346143B (en) | A compound | |
GB2355450B (en) | A carton for fixings | |
IL132519A0 (en) | A food-serving holder | |
GB2349386B (en) | A compound | |
GB9914111D0 (en) | A tool | |
ZA200203967B (en) | Novel processes for making- and a new crystalline form of leflunomide. | |
GB9906874D0 (en) | A compound | |
SI1196431T1 (sl) | V bistvu kristalna oblika melagatrana | |
AU138548S (en) | A holder | |
AU143085S (en) | A holder | |
AU142145S (en) | A brick |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
OBST | Application withdrawn |